This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Public advisory

Unauthorized health product, Slim-30, may pose serious health risks

Starting date:
April 28, 2010
Posting date:
April 28, 2010
Type of communication:
Advisory
Subcategory:
Natural health products
Source of recall:
Health Canada
Issue:
Product Safety, Unauthorized products, Undeclared Substance
Audience:
General Public
Identification number:
RA-110004263

Health Canada is warning Canadians that an unauthorized health product, Slim-30, distributed in Ontario and Quebec by Duxx Enterprises Inc., contains an undeclared pharmaceutical ingredient similar to the prescription drug, sibutramine. Sibutramine may pose serious health risks, particularly to people with heart problems. Consumers who have purchased Slim-30 are advised to consult with a medical professional if they have used the product or have concerns about their health.

Sibutramine is a prescription drug used to treat obesity. The use of sibutramine may cause serious side effects, including cardiovascular reactions, such as increased blood pressure, chest pain, and stroke, in addition to dry mouth, difficulty sleeping and constipation. Sibutramine should be used only under the supervision of a healthcare practitioner. Sibutramine should not be taken by people who have had a heart attack, coronary artery disease, heart-related chest pain, irregular heart beats, congestive heart failure, a stroke or symptoms of a stroke, in individuals with unstable or poorly controlled high blood pressure, or in patients who have clinically diagnosed depression or have a psychiatric illness. Sibutramine is not recommended for women who are pregnant, breastfeeding or planning to become pregnant.

Health Canada is working with the Canada Border Services Agency to stop future importation of any shipments of Slim-30 by Duxx Enterprises Inc. Health Canada has been advised that the product is being voluntarily recalled to the retail level. Health Canada is taking steps to confirm that Slim-30 has been removed from the Canadian market.

Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.

Consumers requiring more information about this advisory can contact Health Canada's public enquiries line at 613-957-2991, or toll-free at 1-866-225-0709.

You can report any adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following three ways:

To have postage pre-paid, download the postage paid label from the MedEffect™ Canada section of the Health Canada website. The Canada Vigilance Reporting Form and the adverse reaction reporting guidelines may also be obtained via this section.


Media enquiries

Health Canada
613-957-2983

Public enquiries

613-957-2991
1-866-225-0709

Images

Select thumbnail to enlarge - opens in a new window


Date modified: